Skip to Main Content

Paper Details

Effectiveness and Safety of High-Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance.
Arthritis Care and Research
3
2022

Datasets

Release 1.2